Correlation Between Beta Drugs and SANOFI S
Specify exactly 2 symbols:
By analyzing existing cross correlation between Beta Drugs and SANOFI S HEALTHC, you can compare the effects of market volatilities on Beta Drugs and SANOFI S and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of SANOFI S. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and SANOFI S.
Diversification Opportunities for Beta Drugs and SANOFI S
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Beta and SANOFI is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and SANOFI S HEALTHC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SANOFI S HEALTHC and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with SANOFI S. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SANOFI S HEALTHC has no effect on the direction of Beta Drugs i.e., Beta Drugs and SANOFI S go up and down completely randomly.
Pair Corralation between Beta Drugs and SANOFI S
Assuming the 90 days trading horizon Beta Drugs is expected to generate 2.03 times more return on investment than SANOFI S. However, Beta Drugs is 2.03 times more volatile than SANOFI S HEALTHC. It trades about 0.11 of its potential returns per unit of risk. SANOFI S HEALTHC is currently generating about -0.01 per unit of risk. If you would invest 175,770 in Beta Drugs on September 2, 2024 and sell it today you would earn a total of 41,415 from holding Beta Drugs or generate 23.56% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 87.3% |
Values | Daily Returns |
Beta Drugs vs. SANOFI S HEALTHC
Performance |
Timeline |
Beta Drugs |
SANOFI S HEALTHC |
Beta Drugs and SANOFI S Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Beta Drugs and SANOFI S
The main advantage of trading using opposite Beta Drugs and SANOFI S positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, SANOFI S can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SANOFI S will offset losses from the drop in SANOFI S's long position.Beta Drugs vs. Reliance Industries Limited | Beta Drugs vs. Tata Consultancy Services | Beta Drugs vs. HDFC Bank Limited | Beta Drugs vs. Bharti Airtel Limited |
SANOFI S vs. Kingfa Science Technology | SANOFI S vs. Rico Auto Industries | SANOFI S vs. GACM Technologies Limited | SANOFI S vs. COSMO FIRST LIMITED |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |